Latest Regulatory Approvals News

Astron Corporation has made significant strides in developing its Donald Rare Earths and Mineral Sands Project, securing $14.5 million in funding and progressing towards a Final Investment Decision in 2025 amid key regulatory and operational milestones.

Berkeley Energia reports promising lithium and rubidium mineralisation at its Conchas Project while advancing a $1 billion arbitration claim against Spain over regulatory setbacks at Salamanca.

Alliance Nickel Ltd has completed a definitive feasibility study for its NiWest Nickel-Cobalt Project, revealing strong financial metrics, increased ore reserves, and strategic collaborations with global automakers. The project is positioned to become a low-cost, sustainable supplier of high-purity nickel and cobalt for the burgeoning electric vehicle market.

INOVIQ's December quarterly update reveals significant progress in its cancer diagnostic and therapeutic programs, including a highly accurate ovarian cancer screening test and promising breast cancer therapeutics, supported by growing EXO-NET customer adoption and a solid cash position.

Cobre Limited’s December 2024 quarterly report reveals promising copper mineralisation in Botswana and a significant high purity quartz target in Western Australia, supported by a successful $4.6 million capital raise.

Pure Hydrogen advances its zero-emission vehicle strategy with key deliveries, US partnerships, and a planned demerger of its natural gas assets into Eastern Gas Limited.

1414 Degrees Ltd reports strong progress in its hydrogen and thermal energy storage projects, securing full funding for commercialisation and advancing key customer agreements. The company is poised to scale its innovative technologies amid ongoing operational enhancements.

Race Oncology has advanced its Phase 1 clinical trial for RC220, submitting ethics approvals and bolstering its cash reserves to $18.78 million following a $5.25 million R&D tax incentive.

Lendlease has agreed to sell Capella Capital for $235 million and completed the $516 million sale of its US Military Housing business, reinforcing its strategy to streamline operations and reduce funding needs.

Simonds Group Limited has agreed to acquire Dennis Family Homes for an estimated $10 million, significantly broadening its product portfolio and market presence in Victoria and New South Wales. The deal is expected to boost revenue by $200 million in FY26 and be earnings accretive by Q1 FY26.

Lakes Blue Energy reported a $1.5 million quarterly operational spend and completed the $6.5 million sale of its 49% interest in PEP 169, while progressing drilling approvals for the Wombat-5 well in Victoria.

Immutep Limited has initiated its pivotal Phase III trial for eftilagimod alfa in first-line non-small cell lung cancer, supported by compelling survival outcomes from ongoing studies and a robust cash position expected to fund operations through 2026.